Humira Psoriasis Data Showing Superiority To Methotrexate Doesn’t Faze Amgen
This article was originally published in The Pink Sheet Daily
Executive Summary
A similar head-to-head trial using Enbrel is not being planned.
You may also be interested in...
Abbott To Seek Humira Psoriasis Indication In 2007
The three-arm Phase III trial “exceeded” Abbott’s expectations and indicates Humira is first biologic treatment “to demonstrate superiority over methotrexate,” company says.
Actelion CEO Jean-Paul Clozel: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
CEO Clozel discusses the firm’s renin inhibitor program in the face of Novartis’ Tekturna, alliances with Merck and Roche and its business strategy going forward.
Actelion CEO Jean-Paul Clozel: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Exec discusses the firm’s pulmonary arterial hypertension drug Tracleer and other endothelin receptor antagonists in Actelion’s pipeline.